CEBPZ and acute myeloid leukemia: For instance, some mutations like NPM1 mutation, RUNX1-RUNX1T1 and CBF-MYH11 in core binding factor (CBF) AML are relatively stable during disease course hereby are suitable for PCR MRD monitoring (12).